Stay updated on Nadunolimab Combo for Triple Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Nadunolimab Combo for Triple Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nadunolimab Combo for Triple Negative Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.3 to v3.6.4. This indicates a new version of the page without changing study content.
    Difference
    0.0%
    Check dated 2026-07-25T13:21:57.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The revision metadata on the page was updated from v3.6.2 to v3.6.3, indicating a refreshed version of the page.
    Difference
    0.0%
    Check dated 2026-07-03T23:55:36.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.0 to v3.6.2, indicating a new version of the study details page. This appears to be a backend/editorial update rather than a change to the study content.
    Difference
    0.0%
    Check dated 2026-06-26T22:31:46.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    New navigation and guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the recruitment status was updated to No longer looking for participants, along with the addition of an Intervention/Treatment item. The old label 'Intervention / Treatment' was removed and the revision note updated from v3.5.5 to v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-12T12:38:28.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    The page revision updated from v3.5.4 to v3.5.5, indicating a small update to the study record page (e.g., formatting or minor corrections) without altering the study data.
    Difference
    0.0%
    Check dated 2026-06-05T10:20:43.000Z thumbnail image
  9. Check
    66 days ago
    Change Detected
    Summary
    The study record now shows a Completed status, with the Primary Completion Date updated to 2026-04-09 and the Study Completion Date updated to 2026-05-08, replacing prior estimated dates. This change clarifies the final timeline of the trial.
    Difference
    0.4%
    Check dated 2026-05-29T07:47:40.000Z thumbnail image

Stay in the know with updates to Nadunolimab Combo for Triple Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nadunolimab Combo for Triple Negative Breast Cancer Clinical Trial page.